FAQ: Unique Device Identification Final Rule
|
|
|
- Brice Walters
- 10 years ago
- Views:
Transcription
1 FAQ: Unique Device Identification Final Rule October 2013 Key Changes from Proposed Rule A separate UDI is not required for devices within a convenience kit, regardless of Class designation, so long as the label of the kit bears a UDI. Single-use devices within multi-packs (i.e., all of a single version or model, intended to be stored in that device package until removed for use, and which are not intended for individual commercial distribution), regardless of class designation, will only be required to print the UDI on the multi-pack (i.e., the next higher level of packaging) and not on the individual device label. Inventories of medical devices manufactured prior to the final rule will be allowed to be sold without UDIs for a period of three years from the compliance date of the device. Class I devices that are sold via retail may use the device s Universal Product Code (UPC) as its UDI on both the device label and highest level of packaging. Combination products may use the product s National Drug Code (NDC) as its UDI on both the product label and the next highest level of packaging. The elimination of the requirement for direct marking of the UDI on implantable devices, allowing the code to be printed on the lowest level of packaging rather than the device. FDA may grant one-year extensions for specific Class III devices if it is deemed to be in the best interest of the public health. UDI Labeling Requirements for Medical Devices Who is considered a labeler (i.e., ultimately responsible for the placement of a UDI) under the final rule? The FDA defines a labeler as someone who causes a label to be applied to a device or causes the label to replaced or modified, with the intent that the device will be commercially distributed. How does the UDI requirement impact wholesale distributors? The adoption of UDI by wholesale distributors is not required by the FDA regulation; however, wholesale distributors that engage in relabeling (i.e., private labeling), reprocessing and/or kitting of their medical devices at receipt will bear the responsibility of placing a UDI on a device label, its packaging, or directly marked on the device itself. Which devices are required to be directly marked with a UDI? Any medical device, with the exception of implantable devices, intended to be used more than once and reprocessed (i.e., cleansed, disinfected, or sterilized) between or before each use must be directly marked (i.e., permanently marked) with a UDI on the device itself. Are there any exemptions for medical devices under the final rule? Yes, there are a number of exemptions under the final rule. Class I devices do not need to include production identifiers in the UDI; the UDI only needs to contain a device identifier.
2 Class I devices that are exempt under the FDA s good manufacturing practice are completely exempt from UDI requirements. All packaged single-use devices (i.e., all of a single version or model, intended to be stored in that device package until removed for use, and which are not intended for individual commercial distribution) are not required to have a UDI on the individual device itself; however, the the UDI is required to be printed on the multi-pack. Implantable medical devices are not required to be directly marked with a UDI; however, the UDI is required to be on the lowest unit of use packaging. Class I devices labeled with a Universal Product Code (UPC) number may use the UPC number as their UDI number on both their device label and package; Class I device labeled with a UPC do not have to have an additional UDI on their device label and package; however, a UDI/UPC is required on both the device label and the highest level of packaging. Combination products that have a properly labeled National Drug Code (NDC) may use the NDC number as their UDI number on the highest level of packaging. Combination products labeled with a NDC do not need to have an additional UDI on their product package; however, unless the combination product is a single entity, a UDI number is required on the device constituents. What medical devices are subject to the UDI labeling requirements? Generally, all medical devices subject to FDA oversight are subject to some aspect of UDI labeling requirements (i.e., UDI directly marked on a device or UDI required on next higher level of packaging; or UDI required on both the device and the next higher level of packaging both scenarios), unless they have received an exemption as noted above. How are convenience kits treated under the final rule? A separate UDI is not required for devices within a convenience kit, regardless of Class designation, so long as the label of the kit bears a UDI. Convenience kits not already classified as Class I, II, or III devices are required to have a UDI based on the compliance date associated with the highest class of device in the kit (e.g., if the kit contains a Class II device the kit would have to meet the September 24, 2016 compliance date). How are Single Use Devices (SUDs) treated under the final rule? Single use medical devices (i.e., all of a single version or model, distributed together in a single device package and not intended for individual sale), regardless of class designation, are not required to have a separate UDI on the device label; however, a UDI and/or UPC number is required on the next highest level of packaging. How are Class I and Over-the-Counter devices treated under the final rule? Class I devices labeled with a Universal Product Code number may use the UPC number as their UDI number; Class I devices labeled with a UPC do not have to have an additional UDI on their label. How does the final rule treat combination products? All combination products much bear a UDI; however, there are some exceptions. If a combination product has a National Drug Code number, then it is exempt from UDI requirement on the highest level of packaging. The NDC on the highest level of packaging will serve as the product s UDI; however, the device constituent parts must have their own UDI unless... A combination product is a single entity (i.e., combination products where the device constituent parts are physically, chemically, or otherwise combined in way that you cannot separate those or use the device separately from the combination product) a separate UDI is not required on the device constituent parts and is only required on the highest level of packaging. How are devices intended to be used more than once and reprocessed (i.e., cleansed, disinfected, or sterilized) between or before each use treated under the final rule? Any medical device, with the exception of implantable devices,
3 that is intended for more than one use and intended to be reprocessed before each use must bear a permanent marking providing the UDI on the device itself. How are implantable devices treated under the final rule? Implantable devices do not have to be directly marked with a UDI; however, a UDI is required at the lowest level of packaging. Which devices will need to be directly marked with a UDI? Any medical device, with the exception of implantable devices, is intended for more than one use and intended to be reprocessed before each use must bear a permanent marking providing the UDI on the device itself. Are there any exceptions to the direct marking requirement? Yes, an exception will be granted if a manufacturer determines that: Direct marking would interfere with the safety or effectiveness of the device; Direct marking is not technologically feasible; The device is a reprocessed single-use device; The device has been previously marked. Any manufacturer who determines that they cannot directly mark their product needs to note that in the design history file of their device. How is stand-alone software treated under the final rule? Stand-alone software has to be able to make the UDI available to the user in plain text when started (e.g., in a help screen or an about screen). If the software is distributed in packaged form, it may use the same UDI for both the package and display screen. The compliance dates for stand-alone software are the same as the class compliance dates. Compliance Dates When will the UDI system be implemented? The UDI system will be implemented in phases over seven years, initially focusing on high-risk medical devices and devices licensed under the Public Health Service Act (e.g., implantable, lifesupporting, and life sustaining devices). September 24, Class III medical device and/or a devices licensed under the Public Health Service Act September 24, Any implantable, life supporting, or life sustaining device not designated by the FDA as Class III September 24, Class II medical devices September 24, Class I medical devices September 24, Any other device not classified into Class I, II, or III September 24, 2020 Class I devices, and devices that have not been classified into Class I, Class II, or Class III that are required to be labeled with a UDI must bear a UDI as a permanent marking on the device itself if the device is intended to be used more than once and intended to be reprocessed before each use. Are there any exceptions to the compliance dates? Yes, exceptions include: The FDA may grant a one-year extension to the compliance date for Class III devices or devices licensed under the Public Health Service Act if it is determined to be in the best interest of the public health.
4 Finished devices that are manufactured and labeled prior to the compliance date may be distributed for an additional three years after the existing compliance date associate with the finished device. UDI Framework What is a Unique Device Identifier (UDI)? A UDI is an alpha-numeric or numeric code, on a device label, its packaging, or directly marked on the device itself. The UDI must be represented in both plain text (i.e., human readable) and machinereadable format (e.g., codes, linear or two-dimensional, or RFID technology). Once fully implemented, the system is poised to help facilitate product recalls and assist in adverse event reporting. What will the UDI consist of? There are two parts to the UDI: 1) the Device Identifier, which is specific to a particular version or model of the device and the labeler of the device (e.g., the person who causes the label to be applied to the device) and; 2) the Production Identifiers, which are control mechanisms currently used on a label or device itself (i.e., lot or batch numbers, serial numbers, manufacturing dates, and expiration dates). The UDI will be created and maintained by the device manufacturer; the manufacturer will also create the device identifiers and the production identifiers for their devices. What does the UDI final rule require? Generally, the label and package (i.e., lowest level of packaging) of every medical device, unless otherwise excluded, must contain a unique number assigned by the manufacturer by the compliance date established for the device. Some devices require direct marking. Once a medical device becomes subject to UDI requirements, medical device labelers are required to update the information reported on the device via the FDA s Global Unique Device Identification Database (GUDID) whenever the information changes. Will any proprietary information be captured in the public side of the Global Unique Device Identification Database (GUDID)? The public side of the GUDID database will not contain any individual contact information, except for optional customerservice information if the submitting company chooses to provide individual contact information for that purpose. HIDA has prepared a separate document outlining the key components of the FDA s draft guidance on the Global Unique Device Identification Database. Does the final rule require a particular production identifier be used? No, the UDI rule does not require any particular production identifier. The production identifiers currently on a device or on the label of a device can be used in the UDI. Does the FDA identify any specific technology that can or cannot be used? The FDA has taken a technology-neutral approach and does not identify any specific technology. Any form of automatic identification technology (e.g., codes, linear or two-dimensional, or RFID technology) is acceptable. What type of standards organization may apply for accreditation? Any private organization (e.g., GS1, HIBCC, ICCBBA) may apply for accreditation as an issuing agency. A manufacturer will choose to work with one of these issuing agencies and will develop a UDI according to the standard of those organizations. Definitions Automatic identification and data capture (AIDC): means any technology that conveys the unique device identifier or the device identifier of a device in a form that can be entered into an electronic patient record or other computer system via an automated process. Expiration date means the date by which the label of a device states the device must or should be used.
5 Finished device: means any device or accessory to any device that is suitable for use or capable of functioning. Global Unique Device Identification Database (GUDID) means the database that serves as a repository of information to facilitate the identification of medical devices through their distribution and use. Lot or batch: means one finished device or more that consist of a single type, model, class, size, composition, or software version that are manufactured under essentially the same conditions and that are intended to have uniform characteristics and quality within specified limits. Label: means a display of written, printed, or graphic matter upon the immediate container of any article; and a requirement made by or under authority of this Act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper. Labeler: means (1) Any person who causes a label to be applied to a device with the intent that the device will be commercially distributed without any subsequent replacement or modification of the label; and (2) Any person who causes the label of a device to be replaced or modified with the intent that the device will be commercially distributed without any subsequent replacement or modification of the label, except that the addition of the name of, and contact information for, a person who distributes the device, without making any other changes to the label, is not a modification for the purposes of determining whether a person is a labeler. Shipping container: means a container used during the shipment or transportation of devices, and whose contents may vary from one shipment to another. Unique device identifier (UDI): means an identifier that adequately identifies a device through its distribution and use. A UDI is composed of: (1) A device identifier--a mandatory, fixed portion of a UDI that identifies the specific version or model of a device and the labeler of that device; and (2) A production identifier--a conditional, variable portion of a UDI that identifies one or more of the following when included on the label of the device: The lot or batch within which a device was manufactured; The serial number of a specific device; The expiration date of a specific device; The date a specific device was manufactured. For an HCT/P regulated as a device, the distinct identification code. Universal Product Code (UPC): means the product identifier used to identify an item sold at retail in the United States. Version or model: means all devices that have specifications, performance, size, and composition, within limits set by the labeler.
UDI Regulatory 101. Erin (Fields) Quencer. UDI Conference October 28-29, 2014 Baltimore, MD. October 28, 2014. Regulatory Analyst, FDA
UDI Regulatory 101 October 28, 2014 Erin (Fields) Quencer Regulatory Analyst, FDA Slide 1 Basic UDI Requirements Device label and device package must bear a UDI, 21 CFR 801.20 Devices intended to be used
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Document issued on August 20, 2014. On November 5, 2014 this document was
Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff
Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff Document issued on August 13, 2014 On November 5, 2014 this document was
Unique Device. Adoption and Use Trends for Medical Devices. Authors: Anya Kroupnik and Susan Moretti
Unique Device Identifier Study Adoption and Use Trends for Medical Devices Authors: Anya Kroupnik and Susan Moretti May 2013 Unique Device Identifier Study Results Table of Contents SECTION I: Executive
EHIMA Guidance Document Revision: V05 Issue date: 2016-01-25
Guidance Document for EHIMA labelling of hearing aids and accessories in accordance with UDI Page 1 of 6 1. Scope This EHIMA guidance document is intended to provide guidance to hearing aid manufacturers
By Natalia Wilson, MD, MPH
White Paper The value of unique device identification across healthcare By Natalia Wilson, MD, MPH Executive summary The Unique Device Identification (UDI) System Proposed Rule was published by the U.S.
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
Information Management FAQ for UDI
White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and
UNIQUE DEVICE IDENTIFICATION (UDI) FOR MEDICAL DEVICES: ECONOMIC ANALYSIS OF THE FINAL RULE
Task Order No. 30 CONTRACT NO. HHSF223200810017I FINAL REPORT UNIQUE DEVICE IDENTIFICATION (UDI) FOR MEDICAL DEVICES: ECONOMIC ANALYSIS OF THE FINAL RULE SUBMITTED TO: FOOD AND DRUG ADMINISTRATION OFFICE
21 CFR Parts 16, 801, 803, 806, 810, 814, 820, 821, 822, and 830
This document is scheduled to be published in the Federal Register on 09/24/2013 and available online at http://federalregister.gov/a/2013-23059, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN
UDI. Guide to Label and Marking Compliance. Unique Device Identification. For Medical Device Manufacturers
Final Rule UDI Unique Device Identification For Medical Device Manufacturers Guide to Label and Marking Compliance UDI Unique Device Identification Table of Contents Introduction... 1 Compliance with FDA
U.S. FDA Unique Device Identification (UDI) Rule Frequently Asked Questions (FAQs) R 2. 3 -- M A R 1 1 2 0 1 4
U.S. FDA Unique Device Identification (UDI) Rule Frequently Asked Questions (FAQs) R 2. 3 -- M A R 1 1 2 0 1 4 CONTENTS DOCUMENT PURPOSE... 6 GENERAL QUESTIONS ABOUT THE U.S. FDA UDI RULE... 7 1. General...
Unique Device Identification Update FDA and GHTF
Unique Device Identification Update FDA and GHTF Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration [email protected] 301-980-1936 UDI Can Improve Visibility Medical device
Unique Device Identification System; Final Rule
4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Unique Device Identification System; Final Rule Docket No. FDA-2011-N-0090 Final Regulatory Impact Analysis Final Regulatory
Global Unique Device Identification Database (GUDID) Guidance for Industry and Food and Drug Administration Staff
Global Unique Device Identification Database (GUDID) Guidance for Industry and Food and Drug Administration Staff Document issued on June 27, 2014. The draft of this document was issued on September 24,
Unique Device Identification Challenges for Manufacturers Focus UDID
Unique Device Identification Challenges for Manufacturers Focus UDID GS1 Healthcare Conference Copenhagen, Oct 22, 2014 Volker Zeinar Global UDI Project Leader FDA s UDI Requirements (Medical Devices)
UDI Systems Comparison Report for Tissue Banks December 20, 2013
This UDI Systems Comparison Report for Tissue Banks provides AATB s membership with an overview of three specific labeling capabilities that will likely be approved by the Food and Drug Administration
Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation
Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation Connie Jung, RPh, PhD U.S. Food and Drug Administration NACDS Total Store Expo August 24, 2014
IMPLEMENTATION GUIDELINE
IMPLEMENTATION GUIDELINE Using the GS1 System for U.S. FDA Unique Device Identification (UDI) Requirements F O R S U P P L I E R S & R E C E I V E R S R 1. 1 S E P 1 2 2 0 1 4 CONTENTS PART 1: PREFACE...
RFID Survives Sterilization to Deliver Medical Device Tracking Solution
RFID Survives Sterilization to Deliver Medical Device Tracking Solution and UDI Compliance Introduction Healthcare providers are increasingly turning to technology solutions to help improve patient outcomes,
How To Help The Global Healthcare User Group (Hug)
HUG Global Healthcare User Group - HUG GS1 s Brand Architecture 2 The global Healthcare User Group - HUG Mission: Lead the healthcare industry to the effective utilization and development of global standards
www.reedtech.com www.reedtech.com 1 800 772 8368 1
www.reedtech.com www.reedtech.com 1 800 772 8368 1 / +1 215 441 6438 Agenda Reed Tech Company Profile FDA UDI / GUDID Refresher 12 Steps for Accurate GUDID Submissions Reed Tech GUDID Submission Solution
The Drug Supply Chain Security Act: Readiness and Implementation Update
The Drug Supply Chain Security Act: Readiness and Implementation Update Connie Jung, RPh, PhD U.S. Food and Drug Administration Center for Drug Evaluation and Research Office of Compliance Office of Drug
DSCSA Updates and Readiness Check: Requirements for Dispensers and other Trading Partners
DSCSA Updates and Readiness Check: Requirements for Dispensers and other Trading Partners U.S. Food and Drug Administration Center for Drug Evaluation and Research July 2015 Who is a Dispenser? DISPENSER.
International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update
International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update Kimberly A. Trautman Associate Director, International Affairs Office of the Center Director
Background and Position on UPN Bar Coding of Medical/Surgical Products in Distribution and Patient Care
Background and Position on UPN Bar Coding of Medical/Surgical Products in Distribution and Patient Care This document describes the format intended for use between a supplier or packager of healthcare
UDI Implementation Reality AIDC Medical devices: How to identify/mark my products?
UDI Implementation Reality AIDC Medical devices: How to identify/mark my products? UDI Implementation Reality Medical devices: How to identify/mark my products? Moderator Ms. Jackie Rae Elkin Global Process
OV E R V I E W A N D G U I D A N C E O N VACC I N E 2 D B A R CO D I N G
Vada Perkins, BSN, MSc, RN CAPT, USPHS, Chief, Business Operations Staff US Food and Drug Administration OV E R V I E W A N D G U I D A N C E O N VACC I N E 2 D B A R CO D I N G "Reviewed April 2013" 2D
AN INTRODUCTION TO THE GLOBAL TRADE ITEM NUMBER (GTIN) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Trade Item Number?... 3 What Is a GTIN Used For?... 3 Key Attributes of the GTIN... 3 Business Benefits of Using GTINs... 3 How Is the GTIN Formed?... 4 Which GTIN Is
Guidance for Industry Bar Code Label Requirements Questions and Answers
Guidance for Industry Bar Code Label Requirements Questions and Answers For questions on the content of this guidance, contact the Center for Drug Evaluation and Research or the Center for Biologics Evaluation
Drug Distribution Management Policy in Korea
Drug Distribution Management Policy in Korea Regarding introduction of Drug Serial Number System (Serialization) Ministry of Health and Welfare Drug Distribution Management Policy Overview Policy Objectives
Transport - track and trace with RFID and latest developments in barcoding
Transport - track and trace with RFID and latest developments in barcoding Thessaloniki, Dr. Knoth 21. April 2012 RFID- Technical data I RFID Radio-Frequency Identification I Uses non-contact identification
GS1 STANDARDS & UDI UPDATE SIOBHAN O BARA GS1US
GS1 STANDARDS & UDI UPDATE SIOBHAN O BARA GS1US AGENDA We have the standards. GS1 US Background and Update We have the framework. Unique Device Identification (UDI) We need to move forward. The clock is
IMPLEMENTATION GUIDELINE
IMPLEMENTATION GUIDELINE Applying GS1 Standards to U.S. Pharmaceutical Supply Chain Business Processes T O S U P P O R T P E D I G R E E A N D T R A C K & T R A C E Release 1.0 (February, 2013) Future
The Health Industry Bar Code Standard:
The Health Industry Bar Code Standard: Frequently asked questions What is HIBCC and the HIBC Standard? HIBCC is the Health Industry Business Communications Council, the primary standard-setting and educational
Documents, Records and Change Control
Documents, Records and Change Control Lori S. Lawless Medical Device Specialist Food and Drug Administration Baltimore District Office [email protected] (410) 779-5442 May 13-14, 2008 Baltimore
PRODUCT RETURN POLICY
PRODUCT RETURN POLICY Effective Date: October, 27, 2015 This Product Return Policy ( Product Return Policy ) is for all Products ( Product or Products ) distributed in the United States by Amgen USA Inc.
California E-Pedigree Update. August 2013
California E-Pedigree Update August 2013 1 Virginia Herold Executive Officer California State Board of Pharmacy www.pharmacy.ca.gov [email protected] 2 2 Statutory Mandate Protection of the public
NOT ALL CODES ARE CREATED EQUAL
NOT ALL CODES ARE CREATED EQUAL Why some serial numbers are better than others. Verify Brand 3033 Campus Drive, Minneapolis MN 55441 [email protected] (763) 235-1400 EXECUTIVE SUMMARY Serial numbers
G. Recalls. http://www.fda.gov/safety/recalls/industryguidance/ucm129259.htm.
G. Recalls 1. Background When an FDA-regulated product is defective, potentially harmful, or mislabeled, recalling that product removing it from the market or correcting the problem is often the most effective
AATB/ICCBBA Interim Guidance Document. For use of ISBT 128 by North American Tissue Banks
AATB/ICCBBA Interim Guidance Document For use of ISBT 128 by North American Tissue Banks Version 1.2.0 September 2012 Published by: ICCBBA PO Box 11309, San Bernardino, California, USA 1.909.793.6516 [email protected]
Global Medical Device Nomenclature (GMDN)
Global Medical Device Nomenclature (GMDN) GMDN A Requirement for UDI Mark Wasmuth CEO, GMDN Agency What we will be discussing Why is the GMDN needed GMDN data structure How to find GMDN terms Unique Device
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE 1 GS1 STANDARDS IN HEALTHCARE Together, we re making it possible to follow drugs and medical devices from the manufacturer
BAR CODE GUIDELINES Revision 12/18/2015
BAR CODE GUIDELINES Revision 12/18/2015 General Bar Code Guidelines Pep Boys has a commitment to increasing supply chain efficiency. Barcode scanning is a proven way to identify products at the item level.
UNIQUE DEVICE IDENTIFICATION. and in the European Union. Laurent SELLES Senior Coordinator for International Relations Health Technology and Cosmetics
GLOBAL GS1 HEALTHCARE CONFERENCE Copenhagen Denmark 22 October 2014 UNIQUE DEVICE IDENTIFICATION Situation in the International Medical Device Regulators Forum (IMDRF) and in the European Union Laurent
HAZARD COMMUNICATION FOR SCHOOLS
HAZARD COMMUNICATION FOR SCHOOLS The Hazard Communication Standard (HCS) is based on a simple concept - that employees have both a need and a right to know the hazards and identities of the chemicals they
AN INTRODUCTION TO THE GLOBAL INDIVIDUAL ASSET IDENTIFIER (GIAI) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Individual Asset Identifier?... 3 What Is a GIAI Used For?... 3 Key Attributes of the GIAI... 3 Business Benefits of Using GIAIs... 3 How Is the GIAI Formed?... 4 Frequently
Guidance for Industry: Starting Material Supplier Management
Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and
AN INTRODUCTION TO THE GLOBAL DOCUMENT TYPE IDENTIFIER (GDTI) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Document Type Identifier?... 3 What Is a GDTI Used For?... 3 Key Attributes of the GDTI... 3 Business Benefits of Using GDTIs... 4 How Is the GDTI Formed?... 4 Frequently
DISTRIBUTOR AGREEMENT
DISTRIBUTOR AGREEMENT This Distributor Agreement (the "Agreement") is entered into as of, 20 ("Effective Date"), by Absoft Corporation ("Absoft"), 2781 Bond Street, Rochester Hills, Michigan 48309, U.S.A.,
Correspondence between ISO 13485:2003 and the US Quality System Regulation
Correspondence between ISO 13485:2003 and the US Quality System Regulation Correspondence between ISO 13485:2003 and the US Quality System Regulation 1 Scope 1.1 General This International Standard specifies
Healthcare GTIN Allocation Rules
Healthcare GTIN Allocation Rules GS1 Global Healthcare User Group Issue 9, Nov-2014 Issue 9, Ratified, Nov-2014 All contents copyright GS1 Page 1 of 28 Document Summary Document Item Document Title Date
Drug Pedigree Requirements for Pharmacies and Wholesalers. State Statutes
Drug Pedigree Requirements for Pharmacies and Wholesalers State Statutes Arizona Revised Statutes Annotated Title 32. Professions and Occupations Chapter 18. Pharmacy Article 3.1. Regulation of Full Service
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC
Guidance for Industry Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions
Position Paper (II) Healthcare Provider Advisory Council Implementation in hospitals hindered by bar code symbol issues
I. Introduction Towards the end of 2011, GS1 Healthcare established the Healthcare Provider Advisory Council (HPAC) to be the forum for sharing and discussing the practical realities of implementation
GS1 Healthcare GTIN Allocation Rules. GTIN Allocation Rules for the Healthcare Sector
GTIN Allocation Rules for the Healthcare Sector Release 9.0.2, Ratified, Dec 2015 Document Summary Document Item Document Name Current Value GS1 Healthcare GTIN Allocation Rules Document Date Dec 2015
Adoption of GS1 and PEPPOL Standards:
Adoption of GS1 and PEPPOL Standards: Guidance for suppliers of medical devices to the NHS Prepared by Commercial Directorate Department of Health June 2015 Contents Introduction... 3 Background... 4 About
Guidance for Industry
Guidance for Industry Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages FINAL GUIDANCE U.S. Department of Health and Human Services Food
The ID Technology. Introduction to GS1 Barcodes
The ID Technology Introduction to GS1 Barcodes Contents GS1 - The Basics 2 Starting Point - GTIN 3 GTIN Labels for Cases - ITF-14 5 Adding More Data - GS1 128 6 GS1 Application Identifiers 7 Logistics
FINAL DOCUMENT. Global Harmonization Task Force. Title: Label and Instructions for Use for Medical Devices
GHTF/SG1/N70:2011 FINAL DOCUMENT Global Harmonization Task Force Title: Label and Instructions for Use for Medical Devices Authoring Group: Study Group 1 of the Global Harmonization Task Force Endorsed
Implementation manual for barcoding using GS1 global standards for tracing and tracking of pharmaceuticals and drugs for exports
Implementation manual for barcoding using GS1 global standards for tracing and tracking of pharmaceuticals and drugs for exports To facilitate compliance with DGFT Public Notice No. 59(RE-2010)/2009-2014
HHSL Barcode Guidelines Version 1.0 - September 2, 2014 HHSL Barcode Guidelines Version 1.0 - September 2, 2014 Page #1 of 14
Table of Contents HHSL Barcode Guidelines Version 1.0 - September 2, 2014 HHSL Barcode Guidelines Version 1.0 - September 2, 2014 Page #1 of 14 Table of Contents Table of Contents: Page # BARCODE GUIDELINES...
Session 5: Unique Device Identifier ASC X12. Margaret Weiker, ASC X12N Chair
Session 5: Unique Device Identifier ASC X12 Margaret Weiker, ASC X12N Chair LEGAL DISCLAIMER This presentation is for informational purposes only. The content should not be construed as legal advice. If
Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products
Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products DRAFT GUIDANCE This guidance document
MEDICAL DEVICE GUIDANCE
May 2014 MEDICAL DEVICE GUIDANCE GN-23: Guidance on Labelling for Medical Devices PREFACE This document is intended to provide general guidance. Although we have tried to ensure that the information contained
Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products
Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments
Medical Device Regulatory Requirements for Mexico
Medical Device Regulatory Requirements for Mexico Updated: June 2011 Disclaimer: The information contained in this profile is derived from public sources, is intended to assist U.S. exporters in performing
UDI as the Cornerstone to Medical Device Data Capture. Presentation to: 27th Global GS1 Healthcare Conference
UDI as the Cornerstone to Medical Device Data Capture Presentation to: 27th Global GS1 Healthcare Conference April 23, 2015 Mexico City The Pew Charitable Trusts Pew is an independent, non-profit research
How To Use The Gs1 Databar Expanded
GS1 Standards GS1 DataBar in the meat industry Compact barcode with additional information for tracking and variable measured trade items GS1 Germany: Your dedicated partner for efficient business processes
ALVERNIA UNIVERSITY OSHA REGULATION: 29 CFR 1910.1200 HAZARD COMMUNICATION SECTION: 1700 REVISION DATE: 2/3/2012 REVISION: 4 NUMBER:
OSHA REGULATION: 29 CFR 90.200 HAZARD COMMUNICATION 700 : DATE: /3/200 DATE: 2/3/202 A. POLICY. This procedure follows requirements set forth in 29 CFR 90.200. 2. It is the policy of Alvernia University
ABSTRACT List of tables List of figures List of abbreviations CHAPTER 1 INTRODUCTION 1.1 Background 1.2 Problem Statement 1.3 Objective 1.4 Scope 1.5 Thesis Organization Chapter 2 2.1 Automatic Identification
Simplification and enhanced accuracy of order processing and receipt
Foreword Project background: Coding for Success The GS1 System of standards is an integrated system of global standards that provides unique accurate identification using bar codes and other data carriers
1083.4 SUPPLY CHAIN INTEGRITY AND SECURITY
BRIEFING 1083.4 Supply Chain Integrity and Security. A new series of general informational chapters describing various aspects of the pharmaceutical supply chain replaces Good Distribution Practices Supply
Coding and Labeling of Medical Devices Using ISBT 128
ISBT 128 STANDARD Coding and Labeling of Medical Devices Using ISBT 128 Version 1.4.0 October 2015 Tracking Number ICCBBA ST-011 ISBN-13: 978-1-933243-56-6 ISBN-10: 1-933243-56-2 Published by: ICCBBA PO
TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H--MEDICAL DEVICES
[Code of Federal Regulations] [Title 21, Volume 8] [Revised as of April 1, 2010] [CITE: 21CFR807] TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES
Guidance for Industry. Required Warnings for Cigarette Packages and Advertisements
Guidance for Industry Required Warnings for Cigarette Packages and Advertisements Small Entity Compliance Guide Written comments and suggestions may be submitted at any time for Agency consideration to
Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR)
Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR) Paul Brooks Healthcare Solutions Disclaimer The new regulations are not finalized and subject to change http://medicaldevices.bsigroup.com/en-us/resources/whitepapers-and-articles/
Fresh Business Practices for Food & Beverage to Meet Today s Top 3 Issues
to Meet Today s Top 3 Issues Prepared exclusively for Sage Software by Industry Directions, Inc. www.industrydirections.com Table of Contents Intro...3 Appealing and Fresh... 3 Compliant and Safe... 4
Global Medical Device Nomenclature (GMDN)
Global Medical Device Nomenclature (GMDN) GMDN A Requirement for UDI Mark Wasmuth CEO, GMDN Agency What we will be discussing Why is the GMDN needed GMDN data structure How to find GMDN terms UDI & GMDN
NMMA I2of5 CARTON LABEL SPECIFICATIONS November 2006
NMMA I2of5 CARTON LABEL SPECIFICATIONS November 2006 Page 1 of 23 NMMA I2of5 Carton Label Specifications TABLE OF CONTENTS INTRODUCTION... 3 PURPOSE... 3 DEFINITIONS... 4 DEFINITION: ITEM... 4 DEFINITION:
SALES AND USE TAX TECHNICAL BULLETINS SECTION 7 PRINTERS, NEWSPAPER OR MAGAZINE PUBLISHERS AND BOOKBINDERS
SECTION 7 - PRINTERS, NEWSPAPER OR MAGAZINE PUBLISHERS AND BOOKBINDERS 7-1 COMMERCIAL PRINTERS AND PUBLISHERS A. All retail sales of tangible personal property by commercial printers or publishers are
856 Advance Ship Notice Supplier Implementation Guide November 2015
856 Advance Ship Notice Supplier Implementation Guide November 2015 856 Ship Notice/Manifest INTRODUCTION This implementation guideline for the 856 Ship Notice/Manifest electronic data interchange (EDI)
White Paper Healthcare Supply Chain Traceability
Executive Summary This white paper focuses on Healthcare supply chain Traceability, from manufacture to patient, going beyond, for example, what is currently regulated by the US 21 CFR Part 820 and ISO
PRODUCTS LIABILITY INSURANCE APPLICATION
HOW TO COMPLETE THIS FORM PRODUCTS LIABILITY INSURANCE APPLICATION To complete this form, you must be a principal, partner, or director of the applicant firm and should make all the necessary inquiries
CDRH Regulated Software Looking back, looking forward
CDRH Regulated Software Looking back, looking forward Medical Device Software Compliance Expert US Food & Drug Administration at the Regulatory Affairs Professional Society Indianapolis, Indiana Goal of
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
How EDI accommodates GS1 GLN & GTIN
This technical document guides a healthcare organization in its implementation of GS1 GLN and GTIN in EDI transaction sets version 4010 and higher. A wide cross section of the healthcare industry collaborated
